Eva Colas Ortega I am principal researcher in the Group of Biomedical Research in Gynecology, where I lead the translational research group. My research interest is to provide solutions for unmet clinical needs in gynecology, mainly in endometrial cancer and endometriosis. We work on biomarker research to provide with innovative solutions and preclinical models to improve personalized medicine. Institutions of which they are part Head of group Biomedical Research in Gynaecology Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Eva Colas Ortega LinkedIn Twitter Orcid Email Institutions of which they are part Head of group Biomedical Research in Gynaecology Vall Hebron Institut de Recerca I am principal researcher in the Group of Biomedical Research in Gynecology, where I lead the translational research group. My research interest is to provide solutions for unmet clinical needs in gynecology, mainly in endometrial cancer and endometriosis. We work on biomarker research to provide with innovative solutions and preclinical models to improve personalized medicine.
I am biologist by formation and fully dedicated to endometrial cancer research for the last 16 years. From 2017, I lead my own team in the Group of Biomedical Research in Gynecology (VHIR) and my research focus on the implementation of molecular diagnostics and personalized medicine in gynecology, mainly in endometrial cancer (EC) and endometriosis. In my career I participated in the development of the first EC patient-derived murine models (PDX), and today, my group owns one of the largest PDX biobanks in Europe, which is used by us, partners and pharma to assess treatments for EC patients. Importantly, I have also grown as a scientist dedicated to biomarker research in gynecological fluids. I worked in the development of the first molecular kit to diagnose EC. Today, I am the European Coordinator of a multicenter study to develop a non-invasive diagnosis of EC (ERA PerMed), and am the founder of a spin-off (MiMARK Diagnostics S.L.) that aims to develop innovative solutions for women health. As a summary, I have a total of 73 scientific articles with impact factor; 17 of them as senior author; and am inventor of 4 patents. My scientific and leadership capacity is proved by the supervision of 12 doctoral theses, 6 of which have already been defended, two of them awarded. I have participated in 32 competitive research projects, being 13 of them principal investigator, and I am actively participating in national (CIBERONC) and international (ENITEC) cancer networks. I have been teaching in graduate and master studies for the last 7 years; and I have been on the Steering Committee of the Societat Catalana de Biologia for 10 years.
Projects Alteraciones moleculares relacionadas con la progresión tumoral en el cáncer de endometrio Numero projecte extern: GCB 110333 REVE IP: Jaume Reventós Puigjaner Collaborators: Eva Colas Ortega, Marta Rebull Santamaria Funding agency: Asociación Española Contra el Cáncer Funding: 1200000 Reference: AECC- GCB 110333 REVE Duration: 01/08/2011 - 28/07/2016 Identification of new molecules and mechanisms of myometrial infiltration and early diagnosis to improve survival in endometrial cancer IP: Jaume Reventós Puigjaner Collaborators: Maria Asuncion Perez Benavente, Eva Colas Ortega, Josep Castellví Vives Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 133100 Reference: SAF2011-26548 Duration: 01/01/2012 - 31/12/2014 Valorización de biomarcadores oncológicos para el desarrollo de kits de diagnóstico/pronóstico para el cáncer de próstata y de pulmón IP: Jaume Reventós Puigjaner Collaborators: Eva Colas Ortega Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 210407 Reference: IPT-2011-1569-010000 Duration: 06/09/2011 - 28/02/2014 Detección de los marcadores precoces (RUNX/AML1 y ER,/ETV5) de invasión miometrial y mestatatización en el carcinoma de endometrio: caracterización de los mecanismos de acción IP: Jaume Reventós Puigjaner Collaborators: Eva Colas Ortega Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 9700 Reference: EEBB-I-2010-00375 Duration: 08/02/2010 - 10/08/2010 Pagination First page « Previous page ‹ … Page 5 Page 6 Page 7 Current page 8 Page 9 Next page › Last page »
